Bharat Parenterals Ltd - 541096 - Closure of Trading Window
Intimation of Trading Window Closure as per SEBI (PIT) Regulations, 201802-07-2019
02-07-2019
Bharat Parenterals Ltd - 541096 - Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report Sr. No. Particulars Details 1Period for which the report has been issued 31/03/2019 2Date of Report29/05/2019 3 Name of the Certifying Firm Jigar Trivedi & Co. 4 Name of the Certifying Individual Mr. Jigar Trivedi 5Membership TypeACS 6 Membership Number 46488 7 CP No. 18483 8 Whether any observations/qualification reported by the Secretarial Auditor ? Yes30-05-2019
Bharat Parenterals Ltd - 541096 - Outcome of Board Meeting
Audited Financial Results for the fourth quarter and financial year ended 31st March, 2019.29-05-2019
Bharat Parenterals Ltd - 541096 - Results For The Fourth Quarter And Financial Year Ended 31St March, 2019.
Audited Financial Results for the fourth quarter and financial year ended 31st March, 2019.29-05-2019
Bharat Parenterals Ltd - 541096 - Board Meeting Intimation for Intimation Of Board Meeting For Audited Financial Results For Quarter And Year Ended On March 31, 2019
Bharat Parenterals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2019 ,inter alia, to consider and approve Board Meeting of the Company shall be held on Wednesday, 29th May, 2019 to transact following business: 1. To consider and approve Audited Financial Results of the Company for the quarter and financial year ended 31st March, 2019. 2. To consider any other matter with the permission of the Chair. Further, we had, vide our letter dated 5th April, 2019, informed the Exchange about Closure of the Trading Window of the Company for dealing in the Company''s securities, as required under the Code of SEBI (Prohibition of Insider Trading) Regulation, 2015 till the completion of 48 hrs. after the declaration of the financial results for the fourth quarter and financial year ended 31st March, 2019.23-05-2019
Bharat Parenterals Ltd - 541096 - Compliances-Certificate under Reg. 54 (5) of SEBI (DP) Regulations, 1996
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended on March 31, 201901-05-2019
Bharat Parenterals Ltd - 541096 - Announcement under Regulation 30 (LODR)-Resignation of Director
Resignation of Whole-Time Director with immediate effect.29-04-2019
Bharat Parenterals Ltd - 541096 - Format of Initial Disclosure to be made by an entity identified as a Large Corporate
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details 1Name of CompayBharat Parenterals Ltd 2CININE365Y01019 3 Outstanding borrowing of company as on 31st March / 31st December, as applicable (in Rs cr) 3 4Highest Credit Rating during the previous FY NA 4aName of the Credit Rating Agency issuing the Credit Rating mentioned in (4)Not Applicable 5Name of Stock Exchange# in which the fine shall be paid, in case of shortfall in the required borrowing under the frameworkBSE We confirm that we are a Large Corporate as per the applicability criteria given under the SEBI circular SEBI/HO/DDHS/CIR/P/2018/144 dated November 26, 2018. No Name of the Company Secretary: MONICA AHIR Designation: Company Secretary & Compliance Officer EmailId: cs@bplindia.in Name of the Chief Financial Officer: Jignesh Shah Designation: CFO EmailId: cfo@bplindia.in Date: 29/04/2019 Note: In terms para of 3.2(ii) of the circular, beginning F.Y 2022, in the event of shortfall in the mandatory borrowing through debt securities, a fine of 0.2% of the shortfall shall be levied by Stock Exchanges at the end of the two-year block period. Therefore, an entity identified as LC shall provide, in its initial disclosure for a financial year, the name of Stock Exchange to which it would pay the fine in case of shortfall in the mandatory borrowing through debt markets.29-04-2019
Bharat Parenterals Ltd - 541096 - Certificate Under Regulation 40(9) Of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015
Certificate under Regulation 40(9) of SEBI (Listing Obligation & Disclosure Requirements) Regulation, 2015, for the half year ended 31st March, 201927-04-2019